Comparative 18F-FDG PET/CT and FAP-targeted PET/CT Findings in Parotid Warthin Tumor
Warthin tumor is the second most common benign parotid neoplasm and often shows marked uptake on 18F-FDG PET/CT, frequently mimicking malignancy. In contrast, its imaging characteristics on fibroblast activation protein (FAP)-targeted PET/CT remain insufficiently defined. We report 2 cases of parotid Warthin tumors that demonstrated marked FDG uptake but absent or minimal uptake on FAP-targeted PET/CT using 68Ga-FAPI-04 and 68Ga-FAP-2286. This discordant imaging pattern suggests that FAP-targeted PET/CT may aid in distinguishing Warthin tumor from malignant lesions.
Authors
- Feiyu Chen (ORCID: https://orcid.org/0009-0002-9098-4447)
- Ke Cheng
- Tingting Xu
- Peng Wang
- Yue Chen
Institutions
- Southwest Medical University (CN)
- Affiliated Hospital of Southwest Medical University (CN)
- Theranostics (New Zealand) (NZ)
- Molecular Theranostics (United States) (US)
Publication Details
- Journal
- Clinical Nuclear Medicine
- Published
- 2026-02-23
- DOI
- https://doi.org/10.1097/rlu.0000000000006392
- Primary Topic
- Peptidase Inhibition and Analysis
- Type
- article
- Field-Weighted Citation Impact
- 0.00